• Home
  • Blog
  • Who We Are
  • Contact
  • Sponsors
Enterprise Irregulars
Smart Thinking for the Smart Enterprise
  • Featured Posts
  • Business
  • Technology / Software
  • Trends & Concepts
  • Startup Lessons

Active ingredient

Will Supply Risk Threaten the Safety of Tomorrow’s Drug Supply?

Will Supply Risk Threaten the Safety of Tomorrow’s Drug Supply?

By Jason Busch on November 4, 2010

Even though this article only highlights the findings from a recent PWC and Axendia study looking at the future of the pharmaceutical supply chain, it echoes a number of the things I’ve heard from industry procurement and operatio…

Posted in Business | Tagged Active ingredient, drug supply, Pharmaceutical drug, supply chain, supply risk

feed mail facebook twitter linkedin

EI Tweets

My Tweets

Popular Posts

  • Accenture: 'Branded' by the Tiger Woods mess
  • The City of Orlando and the Workday contract
  • Five Cloud/SaaS Contract Negotiation Tips For 2012
  • Friday Rant: Coupa Sam Talks Smack to Ariba Spendman
  • 2021 Roundup Of AI And Machine Learning Market Forecasts Show Strong Growth
  • Painting And HR Technology — Yes, There’s A Connection
  • Well-spent Workday @ Workday–Here’s the Firehose
  • Three types of GUIs - past, present and the future

Archives

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Authors

  • Anshu Sharma
  • Bob Warfield
  • Brian Sommer
  • Dave Kellogg
  • David Terrar
  • Denis Pombriant
  • Dion Hinchcliffe
  • Esteban Kolsky
  • Evangelos Simoudis
  • James Governor
  • Jason Corsello
  • Jason M. Lemkin
  • Louis Columbus
  • Michael Krigsman
  • Naomi Bloom
  • Paul Greenberg
  • Phil Fersht
  • R "Ray" Wang
  • Raju Vegesna
  • Ross Mayfield
  • Sameer Patel
  • Sandy Kemsley
  • Susan Scrupski
  • Thomas Otter
  • Tom Raftery
  • Vijay Vijayasankar
  • Vinnie Mirchandani
  • Zoli Erdos